Skip to main content
Erschienen in: Journal of Artificial Organs 4/2017

04.07.2017 | Original Article

Differences in CVVH vs. CVVHDF in the management of sepsis-induced acute kidney injury in critically ill patients

Erschienen in: Journal of Artificial Organs | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

We hypothesized that patients with sepsis and AKI, especially patients without preserved renal function, and treated with continuous veno-venous hemodiafiltration (CVVHDF), have lower risk for mortality than patients treated with continuous veno-venous hemofiltration (CVVH). Patients were included if they fulfilled the diagnosis of severe sepsis or septic shock, suffered AKI and received continuous renal replacement therapy (CRRT) in intensive care unit. There were 62 patients treated by CVVH and 75 treated by CVVHDF. Mean survival time was longer in CVVHDF group with oliguric/anuric patients than in CVVH group. CVVH, and not classic risk factors, was associated with higher overall mortality in oliguric/anuric patients. In the linear regression model, hourly urine output was the strongest and positive predictor of longer survival. CVVHDF is according to our results a CRRT modality of choice for the treatment and lower mortality of septic patients with AKI where renal function is no longer preserved. CRRT has been associated with improved renal recovery, but it should be started earlier in AKI evolution with still preserved hourly urine output which is the most sensitive and prognostic marker of survival in septic patients with AKI.
Literatur
1.
Zurück zum Zitat Bone RC, Balk RA, Cerra FB, et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–74.CrossRef Bone RC, Balk RA, Cerra FB, et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–74.CrossRef
3.
Zurück zum Zitat Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801–10.CrossRefPubMedPubMedCentral Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801–10.CrossRefPubMedPubMedCentral
5.
6.
Zurück zum Zitat Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813–8.CrossRefPubMed Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813–8.CrossRefPubMed
7.
Zurück zum Zitat Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med. 2008;36:S198–203.CrossRefPubMed Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med. 2008;36:S198–203.CrossRefPubMed
8.
Zurück zum Zitat Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation. 2006;114:1572–80.CrossRefPubMed Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation. 2006;114:1572–80.CrossRefPubMed
9.
Zurück zum Zitat Kidney Disease Outcomes Quality Initiative. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:8.CrossRef Kidney Disease Outcomes Quality Initiative. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:8.CrossRef
10.
Zurück zum Zitat Andrikos E, Tseke P, Balafa O, Cruz DN, Tsinta A, Androulaki M, et al. Epidemiology of acute renal failure in ICUs: a multi-center prospective study. Blood Purif. 2009;28:239–44.CrossRefPubMed Andrikos E, Tseke P, Balafa O, Cruz DN, Tsinta A, Androulaki M, et al. Epidemiology of acute renal failure in ICUs: a multi-center prospective study. Blood Purif. 2009;28:239–44.CrossRefPubMed
11.
Zurück zum Zitat Bagshaw SM, George C, Bellomo R. ANZICS database management committee early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008;12:R47.CrossRefPubMedPubMedCentral Bagshaw SM, George C, Bellomo R. ANZICS database management committee early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008;12:R47.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007;2:431–9.CrossRefPubMed Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007;2:431–9.CrossRefPubMed
14.
Zurück zum Zitat Prowle JR, Bellomo B. Sepsis-associated acute kidney injury: macrohemodynamic and microhemodynamic alterations in the renal circulation. Semin Nephrol. 2015;35:64–74.CrossRefPubMed Prowle JR, Bellomo B. Sepsis-associated acute kidney injury: macrohemodynamic and microhemodynamic alterations in the renal circulation. Semin Nephrol. 2015;35:64–74.CrossRefPubMed
15.
Zurück zum Zitat RENAL Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, et al. Intensity of continuous renal- replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627–38.CrossRef RENAL Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, et al. Intensity of continuous renal- replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627–38.CrossRef
16.
Zurück zum Zitat Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Choudhury D, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7–20.CrossRefPubMed Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Choudhury D, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7–20.CrossRefPubMed
17.
Zurück zum Zitat Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med. 2001;29:1910–5.CrossRefPubMed Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med. 2001;29:1910–5.CrossRefPubMed
18.
Zurück zum Zitat AlEnezi F, Alhazzani W, Ma J, Alanazi S, Salib M, Attia M, Thabane L, Fox-Robichaud A. Continuous venovenous hemofiltration versus continuous venovenous hemodiafiltration in critically ill patients: a retrospective cohort study from a Canadian tertiary centre. Can Resp J. 2014;21:176–80. AlEnezi F, Alhazzani W, Ma J, Alanazi S, Salib M, Attia M, Thabane L, Fox-Robichaud A. Continuous venovenous hemofiltration versus continuous venovenous hemodiafiltration in critically ill patients: a retrospective cohort study from a Canadian tertiary centre. Can Resp J. 2014;21:176–80.
19.
Zurück zum Zitat Prowle JR, Liu YL, Licari E, Bagshaw SM, Egi M, Haase M, et al. Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care. 2011;15:R172.CrossRefPubMedPubMedCentral Prowle JR, Liu YL, Licari E, Bagshaw SM, Egi M, Haase M, et al. Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care. 2011;15:R172.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Macedo E, Malhotra R, Claure-Del Granado R, Fedullo P, Mehta RL. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transpl. 2011;26:509–15.CrossRef Macedo E, Malhotra R, Claure-Del Granado R, Fedullo P, Mehta RL. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transpl. 2011;26:509–15.CrossRef
21.
Zurück zum Zitat Joannes-Boyau O, Honore PM, Perez P, Bagshaw SM, Grand H, Canivet JL, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med. 2013;39:1535–46.CrossRefPubMed Joannes-Boyau O, Honore PM, Perez P, Bagshaw SM, Grand H, Canivet JL, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med. 2013;39:1535–46.CrossRefPubMed
22.
Zurück zum Zitat Zhang P, Yang Y, Lv R, Zhang Y, Xie W, Chen J. Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transplant. 2012;27:967–73.CrossRefPubMed Zhang P, Yang Y, Lv R, Zhang Y, Xie W, Chen J. Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transplant. 2012;27:967–73.CrossRefPubMed
23.
Zurück zum Zitat Grootendorst AF. The potential role of hemofiltration in the treatment of patients with septic shock and multiple organ dysfunction syndrome. Adv Renal Replace Ther. 1994;1:176–84.CrossRef Grootendorst AF. The potential role of hemofiltration in the treatment of patients with septic shock and multiple organ dysfunction syndrome. Adv Renal Replace Ther. 1994;1:176–84.CrossRef
24.
Zurück zum Zitat Wakabayashi Y, Kamijou Y, Soma K, Ohwada T. Removal of circulating cytokines by continuous haemofiltration in patients with systemic inflammatory response syndrome or multiple organ dysfunction syndrome. Br J Surg. 1996;83:393–4.CrossRefPubMed Wakabayashi Y, Kamijou Y, Soma K, Ohwada T. Removal of circulating cytokines by continuous haemofiltration in patients with systemic inflammatory response syndrome or multiple organ dysfunction syndrome. Br J Surg. 1996;83:393–4.CrossRefPubMed
25.
Zurück zum Zitat Braun N, Giolai M, Rosenfeld S, Banzhaff W, Fretschner R, Weinstock C, Erley C, Muller GA, Warth H, Northoff H, Risler T. Clearance of interleukin-6 during continuous veno-venous hemofiltration in patients with septic shock: a prospective, controlled clinical study [Abstract]. J Am Soc Nephrol. 1993;4:336. Braun N, Giolai M, Rosenfeld S, Banzhaff W, Fretschner R, Weinstock C, Erley C, Muller GA, Warth H, Northoff H, Risler T. Clearance of interleukin-6 during continuous veno-venous hemofiltration in patients with septic shock: a prospective, controlled clinical study [Abstract]. J Am Soc Nephrol. 1993;4:336.
26.
Zurück zum Zitat Graziani G, Bordone G, Bellato V, Finazzi S, Angelini C, Badalamenti S. Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study. J Nephrol. 2006;19:176–82.PubMed Graziani G, Bordone G, Bellato V, Finazzi S, Angelini C, Badalamenti S. Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study. J Nephrol. 2006;19:176–82.PubMed
27.
Zurück zum Zitat Goldfarb S, Golper TA. Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol. 1994;5:228–32.PubMed Goldfarb S, Golper TA. Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol. 1994;5:228–32.PubMed
28.
Zurück zum Zitat Ronco C, Tetta C, Lupi A, Galloni E, Bettini MC, Sereni L, Mariano F, DeMartino A, Montrucchio G, Camussi G, La Greca G. Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med. 1995;23:99–107.CrossRefPubMed Ronco C, Tetta C, Lupi A, Galloni E, Bettini MC, Sereni L, Mariano F, DeMartino A, Montrucchio G, Camussi G, La Greca G. Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med. 1995;23:99–107.CrossRefPubMed
Metadaten
Titel
Differences in CVVH vs. CVVHDF in the management of sepsis-induced acute kidney injury in critically ill patients
Publikationsdatum
04.07.2017
Erschienen in
Journal of Artificial Organs / Ausgabe 4/2017
Print ISSN: 1434-7229
Elektronische ISSN: 1619-0904
DOI
https://doi.org/10.1007/s10047-017-0970-9

Weitere Artikel der Ausgabe 4/2017

Journal of Artificial Organs 4/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.